{"id":"https://openalex.org/W120612427","doi":null,"title":"Phase II study of doxorubicin versus epirubicin in advanced breast cancer.","display_name":"Phase II study of doxorubicin versus epirubicin in advanced breast cancer.","publication_year":1986,"publication_date":"1986-02-01","ids":{"openalex":"https://openalex.org/W120612427","mag":"120612427","pmid":"https://pubmed.ncbi.nlm.nih.gov/3456271"},"language":"en","primary_location":{"id":"pmid:3456271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3456271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reports","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067094608","display_name":"Cristina Brambilla","orcid":"https://orcid.org/0000-0002-3201-8315","observed_orcids":["https://orcid.org/0000-0002-3201-8315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Brambilla","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103582521","display_name":"Anna Rossi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Rossi","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025152199","display_name":"Valeria Bonfante","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Bonfante","raw_affiliation_strings":["Istituto Nazionale Ricerca Cancer, Milan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Ricerca Cancer, Milan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018594347","display_name":"L. Ferrari","orcid":"https://orcid.org/0000-0001-5364-5396","observed_orcids":["https://orcid.org/0000-0001-5364-5396"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"L Ferrari","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F Villani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Villani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111659143","display_name":"Flavio Crippa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F Crippa","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023558260","display_name":"Gianni Bonadonna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Bonadonna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.216,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.75457676,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"70","issue":"2","first_page":"261","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":1.0},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/cmf-chemotherapy","display_name":"CMF chemotherapy","score":0.6010000109672546},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5379999876022339},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9070000052452087},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.9879999756813049},{"id":"https://openalex.org/keywords/left-ventricular-failure","display_name":"left ventricular failure","score":0.9679999947547913},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.5920000076293945},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.800000011920929},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.925000011920929}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.9774681329727173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9051892161369324},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8297291398048401},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7177591323852539},{"id":"https://openalex.org/C151032500","wikidata":"https://www.wikidata.org/wiki/Q5194182","display_name":"Cumulative dose","level":2,"score":0.6721553802490234},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5467320084571838},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.531825840473175},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.526710569858551},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.495418906211853},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.44390714168548584},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.4402523338794708},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3865036070346832},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31577184796333313}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000505","descriptor_name":"Alopecia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009059","descriptor_name":"Mouth Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3456271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3456271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reports","raw_type":"Clinical Trial"},{"id":"mag:120612427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3456271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2265230738","https://openalex.org/W1888375872","https://openalex.org/W2016830339","https://openalex.org/W2472770723","https://openalex.org/W1526433935","https://openalex.org/W2404278139","https://openalex.org/W1998260358","https://openalex.org/W2052319471","https://openalex.org/W12356482","https://openalex.org/W2025224951"],"abstract_inverted_index":{"Doxorubicin":[0,101],"and":[1,36,51,72,95,102,144,205,216],"its":[2],"epimerized":[3],"analog":[4],"epirubicin":[5,103,153],"were":[6,29,99,146,164],"tested":[7],"at":[8,200,214,235],"a":[9,105,171,188],"dose":[10,43,190],"of":[11,27,66,75,93,114,119,134,139,152,197,203,230],"75":[12],"mg/m2":[13,46,53],"given":[14,126,234],"iv":[15],"every":[16],"3":[17],"weeks":[18],"to":[19,123,156,222],"42":[20],"patients":[21,68,77,112],"with":[22,128],"advanced":[23],"breast":[24,231],"cancer,":[25],"23":[26],"whom":[28],"in":[30,64,73,109,174,182],"relapse":[31],"from":[32],"prior":[33],"cyclophosphamide,":[34],"methotrexate,":[35],"5-FU":[37],"(CMF)":[38],"chemotherapy.":[39],"The":[40,81],"median":[41,82,91,97],"cumulative":[42,189,201],"was":[44,62,85,180],"540":[45],"(range,":[47,54,88],"225-650)":[48],"for":[49,56,227],"doxorubicin":[50,71,186,198],"565":[52],"150-600)":[55],"epirubicin.":[57,80],"Complete":[58],"plus":[59],"partial":[60],"response":[61,94,107],"documented":[63,147,181],"11":[65,120],"21":[67,76],"(52%)":[69],"following":[70,79,150,187],"13":[74,135],"(62%)":[78],"observation":[83],"period":[84],"22":[86],"months":[87],"14-30);":[89],"the":[90,96,167,175,228],"duration":[92],"survival":[98],"superimposable.":[100],"exhibited":[104],"superior":[106],"rate":[108],"previously":[110,125],"untreated":[111],"[six":[113],"eight":[115,118],"(75%)":[116],"vs":[117,137],"(73%)]":[121],"compared":[122,155],"those":[124],"CMF":[127],"or":[129],"without":[130],"endocrine":[131],"therapy":[132,199],"[five":[133],"(38%)":[136],"five":[138],"ten":[140],"(50%)].":[141],"Vomiting,":[142],"mucositis,":[143],"leukopenia":[145],"less":[148,239],"frequently":[149],"administration":[151],"as":[154],"doxorubicin.":[157,242],"Regarding":[158],"cardiac":[159],"evaluation,":[160],"no":[161],"significant":[162,172],"differences":[163],"evident":[165],"between":[166],"two":[168,208],"drugs.":[169],"However,":[170],"fall":[173],"left":[176,211],"ventricular":[177,212],"ejection":[178],"fraction":[179],"women":[183,209],"who":[184],"received":[185],"greater":[191],"than":[192,241],"550":[193],"mg/m2.":[194],"Following":[195],"completion":[196],"doses":[202],"580":[204],"562":[206],"mg/m2,":[207],"developed":[210],"failure":[213],"6":[215],"14":[217],"months,":[218],"respectively.":[219],"Epirubicin":[220],"appears":[221],"be":[223],"an":[224],"effective":[225],"drug":[226],"treatment":[229],"cancer":[232],"and,":[233],"equal":[236],"doses,":[237],"is":[238],"toxic":[240]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}